Understanding the Benefits of Bebtelovimab: A Patient Information
bebtelovimab, the novel monoclonal antibody, has been designed to specifically target b-cell receptor (bcr) signalling pathway. it is currently being developed for the treatment of chronic lymphocytic leukaemia and follicular…
